Xu Tuo, Song Shuaiwei, Zhu Ke, Yang Yin, Wu Chengyu, Wang Naixue, Lu Shu
Xinxiang Central Hospital, Xinxiang, Henan, People's Republic of China.
The Fourth Clinical College of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
Sci Rep. 2025 Jan 14;15(1):1908. doi: 10.1038/s41598-024-81860-7.
Sepsis is a severe infectious disease with high mortality. However, the indicators used to evaluate its severity and prognosis are relatively complicated. The systemic inflammatory response index (SIRI), a new inflammatory indicator, has shown good predictive value in chronic infection, stroke, and cancer. The purpose of this study was to investigate the connection between sepsis and SIRI and evaluate its predictive usefulness. A total of 401 patients with sepsis were included in this study. Multiple linear regression and logistic regression analyses were performed to evaluate the relationship between SIRI and sepsis. The restricted cubic spline (RCS) method was employed to illustrate the dose-response relationship. The area under the curve (AUC) and decision curve analysis (DCA) were used to evaluate the prognostic value of SIRI. Multiple linear regression analysis revealed a significant positive correlation between SIRI and both blood cell count and Sequential Organ Failure Assessment (SOFA) score. Additionally, higher SIRI levels were significantly linked to a higher risk of sepsis worsening, according to logistic regression analysis. The RCS curve demonstrated that the risk of poor prognosis rose with increasing SIRI, particularly when SIRI exceeded 6.1. Furthermore, AUC and DCA results showed that SIRI had superior predictive value compared to traditional indicators. A higher SIRI is linked to a worse prognosis and more severe sepsis. SIRI may serve as a novel prognostic indicator in sepsis, though further clinical studies are necessary to confirm these findings.
脓毒症是一种死亡率很高的严重感染性疾病。然而,用于评估其严重程度和预后的指标相对复杂。全身炎症反应指数(SIRI)作为一种新的炎症指标,在慢性感染、中风和癌症中已显示出良好的预测价值。本研究的目的是探讨脓毒症与SIRI之间的联系,并评估其预测效用。本研究共纳入401例脓毒症患者。进行多元线性回归和逻辑回归分析以评估SIRI与脓毒症之间的关系。采用限制立方样条(RCS)方法来说明剂量反应关系。使用曲线下面积(AUC)和决策曲线分析(DCA)来评估SIRI的预后价值。多元线性回归分析显示SIRI与血细胞计数和序贯器官衰竭评估(SOFA)评分均呈显著正相关。此外,根据逻辑回归分析,较高的SIRI水平与脓毒症恶化风险较高显著相关。RCS曲线表明,随着SIRI升高,预后不良风险增加,尤其是当SIRI超过6.1时。此外,AUC和DCA结果显示,与传统指标相比,SIRI具有更好的预测价值。较高的SIRI与更差的预后和更严重的脓毒症相关。SIRI可能作为脓毒症的一种新的预后指标,不过还需要进一步的临床研究来证实这些发现。